Disclosure Of First-Time Adoption [Text Block]

Egetis Therapeutics - Filing #690710

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
5,062,000,000 SEK
61,000,000 SEK
9,396,000,000 SEK
113,000,000 SEK
1 428,4 SEK
7,458,000,000 SEK
13,000,000 SEK
12,628,000,000 SEK
5,270,000,000 SEK
87,000,000 SEK
6,412,000,000 SEK
1 262,8 SEK
87,000,000 SEK
4,000,000 SEK
6,307,000,000 SEK
Comprehensive income
SEK
SEK
1,938,000,000 SEK
1,938,000,000 SEK
SEK
SEK
SEK
SEK
1,045,000,000 SEK
1,045,000,000 SEK
Profit (loss)
1,938,000,000 SEK
1,045,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.